Akari Therapeutics (AKTX) Enterprise Value Growth (1y) (2012 - 2026)
Akari Therapeutics (AKTX) Enterprise Value Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.04% |
| Dec 31, 2025 | -95.68% |
| Sep 30, 2025 | 92.76% |
| Jun 30, 2025 | 33.66% |
| Mar 31, 2025 | -101.68% |
| Dec 31, 2024 | 30.85% |
| Dec 31, 2023 | 70.98% |
| Sep 30, 2020 | -96.50% |
| Jun 30, 2020 | -365.76% |
| Mar 31, 2020 | -27.28% |
| Dec 31, 2019 | -998.38% |
| Dec 31, 2018 | -266.88% |
| Dec 31, 2017 | 99.68% |
| Dec 31, 2016 | 35.98% |
| Mar 31, 2016 | -4,523.41% |
| Dec 31, 2015 | -1,971.24% |
| Sep 30, 2015 | -149,618.49% |
| Jun 30, 2015 | 76.07% |
| Mar 31, 2015 | 90.39% |
| Dec 31, 2014 | -501.00% |